- Home
- CTRE vs CORT Comparison
CTRE vs CORT Comparison
Compare CTRE & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTRE | CORT |
|---|---|---|
| Founded | 2013 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 8.6B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CTRE | CORT |
|---|---|---|
| Price | $36.05 | $35.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $40.00 | ★ $111.00 |
| AVG Volume (30 Days) | 1.8M | ★ 2.4M |
| Earning Date | 02-11-2026 | 02-25-2026 |
| Dividend Yield | ★ 3.69% | N/A |
| EPS Growth | ★ 90.43 | N/A |
| EPS | ★ 1.34 | 0.87 |
| Revenue | $428,478,000.00 | ★ $741,172,000.00 |
| Revenue This Year | $23.27 | $23.96 |
| Revenue Next Year | $27.02 | $43.40 |
| P/E Ratio | ★ $27.00 | $43.73 |
| Revenue Growth | ★ 59.24 | 17.92 |
| 52 Week Low | $24.79 | $32.99 |
| 52 Week High | $38.32 | $117.33 |
Technical Indicators
Market Signals| Indicator | CTRE | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 43.90 | 16.99 |
| Support Level | $36.57 | $32.99 |
| Resistance Level | $37.25 | $85.34 |
| Average True Range (ATR) | 0.64 | 4.09 |
| MACD | -0.09 | -5.91 |
| Stochastic Oscillator | 54.38 | 4.61 |
Price Performance
Historical ComparisonAbout CTRE CareTrust REIT Inc.
CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.